Home > Boards > US Listed > Medical - Healthcare > GENPREX (GNPX)

News: $GNPX Genprex Reports Positive Preclinical Data for

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
whytestocks Member Profile
Member Level 
Followed By 57
Posts 7,156
Boards Moderated 1
Alias Born 06/04/18
160x600 placeholder
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) Edgar (US Regulatory) - 12/10/2019 5:27:34 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/22/2019 4:05:54 PM
Small Company Offering and Sale of Securities Without Registration (d) Edgar (US Regulatory) - 11/22/2019 3:59:22 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 11/22/2019 9:23:25 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 11/21/2019 4:07:35 PM
Genprex Announces $1.26 Million Registered Direct Offering Business Wire - 11/20/2019 11:15:00 AM
Genprex Reports Positive Preclinical Data for the Treatment of Some of the Most Resistant Metastatic Lung Cancers Business Wire - 11/19/2019 8:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/14/2019 12:10:02 PM
Genprex Issues Lung Cancer Prevention Measures in Support of Lung Cancer Awareness Month Business Wire - 11/4/2019 8:00:00 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 10/29/2019 6:01:04 AM
Amended Quarterly Report (10-q/a) Edgar (US Regulatory) - 10/16/2019 5:25:59 PM
Amended Quarterly Report (10-q/a) Edgar (US Regulatory) - 10/16/2019 5:25:27 PM
Amended Annual Report (10-k/a) Edgar (US Regulatory) - 10/16/2019 5:24:57 PM
Genprex to Present at the MicroCap Rodeo Investor Conference Business Wire - 10/9/2019 8:00:00 AM
Genprex’s Pioneering Use of Non-Viral Delivery for Gene Therapy is Gaining Industry Support Business Wire - 10/7/2019 8:00:00 AM
Securities Registration Statement (simplified Form) (s-3/a) Edgar (US Regulatory) - 10/4/2019 4:00:31 PM
Genprex (GNPX) Featured in Audio Publication Discussing New Research on Breast Cancer Treatment GlobeNewswire Inc. - 9/26/2019 8:30:00 AM
Genprex (GNPX) Featured in Publication on Advances in Potential Breast Cancer Treatments GlobeNewswire Inc. - 9/25/2019 8:30:00 AM
Gene Therapies with Potential to Conquer Tough-to-Tackle Breast Cancers NetworkNewsWire - 9/24/2019 8:45:00 AM
Genprex to Present Via Webcast at the Singular Research Midwestern Values Conference on September 19, 2019 Business Wire - 9/18/2019 8:00:00 AM
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 9/16/2019 6:02:48 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/13/2019 1:23:20 PM
Independent Researchers Find Genprex’s TUSC2 Prevents Tumor Growth in Triple-Negative Breast Cancer Business Wire - 9/11/2019 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/9/2019 1:12:33 PM
CORRECTING and REPLACING Genprex to Present at the H.C. Wainwright 21st Annual Global Investment Conference Business Wire - 9/7/2019 4:35:00 PM
whytestocks Member Level  Tuesday, 11/19/19 10:19:33 AM
Re: None
Post # of 77 
News: $GNPX Genprex Reports Positive Preclinical Data for the Treatment of Some of the Most Resistant Metastatic Lung Cancers

Company’s TUSC2 gene therapy found to increase effectiveness of anti-PD1 immunotherapy and anti-PD1 immunotherapy combined with platinum chemotherapy in humanized mouse model TUSC2 in combination with anti-PD1 and chemotherapy resulted in complete eradication of anti-PD1 resi...

Find out more GNPX - Genprex Reports Positive Preclinical Data for the Treatment of Some of the Most Resistant Metastatic Lung Cancers

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist